AU2003232176A1 - Protein c variants with altered properties - Google Patents
- ️Wed Dec 31 2003
AU2003232176A1 - Protein c variants with altered properties - Google Patents
Protein c variants with altered propertiesInfo
-
Publication number
- AU2003232176A1 AU2003232176A1 AU2003232176A AU2003232176A AU2003232176A1 AU 2003232176 A1 AU2003232176 A1 AU 2003232176A1 AU 2003232176 A AU2003232176 A AU 2003232176A AU 2003232176 A AU2003232176 A AU 2003232176A AU 2003232176 A1 AU2003232176 A1 AU 2003232176A1 Authority
- AU
- Australia Prior art keywords
- variants
- protein
- altered properties
- altered
- properties Prior art date
- 2002-06-14 Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38889202P | 2002-06-14 | 2002-06-14 | |
US60/388,892 | 2002-06-14 | ||
PCT/DK2003/000392 WO2003106666A2 (en) | 2002-06-14 | 2003-06-13 | Protein c variants with altered properties |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003232176A1 true AU2003232176A1 (en) | 2003-12-31 |
AU2003232176A8 AU2003232176A8 (en) | 2003-12-31 |
Family
ID=29736559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003232176A Abandoned AU2003232176A1 (en) | 2002-06-14 | 2003-06-13 | Protein c variants with altered properties |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003232176A1 (en) |
WO (1) | WO2003106666A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004113385A1 (en) * | 2003-06-20 | 2004-12-29 | Maxygen Holdings Ltd. | Protein c propeptide variants |
WO2006044294A2 (en) * | 2004-10-14 | 2006-04-27 | Eli Lilly And Company | Human protein c analogs |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY110664A (en) * | 1992-05-21 | 1999-01-30 | Lilly Co Eli | Protein c derivatives |
SE9701228D0 (en) * | 1997-04-03 | 1997-04-03 | Bjoern Dahlbaeck | Recombinant protein C and protein S variants |
JP4071105B2 (en) * | 2000-10-18 | 2008-04-02 | マキシゲン・エイピーエス | Protein C or activated protein C-like molecule |
-
2003
- 2003-06-13 WO PCT/DK2003/000392 patent/WO2003106666A2/en not_active Application Discontinuation
- 2003-06-13 AU AU2003232176A patent/AU2003232176A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003232176A8 (en) | 2003-12-31 |
WO2003106666A3 (en) | 2007-11-15 |
WO2003106666A2 (en) | 2003-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003201727A1 (en) | 2003-07-24 | Recombinant protein expression |
AU2003285656A1 (en) | 2004-07-14 | System with macrocommands |
AU2002354472A1 (en) | 2004-03-29 | Combine |
AU2003260787A1 (en) | 2004-03-29 | Protein kinases |
EP1572168A3 (en) | 2005-09-22 | Anti-infarction molecules |
AU2003298156A1 (en) | 2004-07-09 | Biphenylcarboxamides |
AU2002355026A1 (en) | 2004-04-30 | Combine |
AU2003254001A1 (en) | 2004-03-03 | Novel htnfsf13b protein variants |
AU2003202694A1 (en) | 2003-09-02 | Torero protein |
AU2003232176A1 (en) | 2003-12-31 | Protein c variants with altered properties |
AU2003278718A1 (en) | 2004-03-11 | Stars-a muscle-specification-binding protein |
AU2003289400A1 (en) | 2004-07-09 | D-aminoacylase |
AU2003270055A1 (en) | 2004-03-29 | Neurotransmission-associated proteins |
EP1504541B8 (en) | 2012-08-29 | Rake-demodulator with multicode-finger |
AU2003285824A1 (en) | 2004-06-23 | Potatoes with increased protein content |
AU2003300785A1 (en) | 2004-06-03 | Carbohydrate-associated proteins |
AU2003254865A1 (en) | 2004-02-25 | Akt2-BINDING PROTEIN |
AU2003292721A1 (en) | 2004-07-29 | Novel protein and its gene |
AU2003270247A1 (en) | 2004-05-13 | Echo-suppression with short delay |
AU2003201994A1 (en) | 2003-07-24 | Level-lit |
AU2003295760A1 (en) | 2004-06-18 | Organelle-associated proteins |
AU2003236908A1 (en) | 2004-01-06 | Proteins |
AU2003281671A1 (en) | 2004-02-16 | Brca1-interacting protein |
AU2003218714A1 (en) | 2003-09-22 | Rhomboid-related protein |
AU2003244272A1 (en) | 2004-01-06 | Segment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
2005-03-03 | MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | |
2005-08-18 | TH | Corrigenda |
Free format text: IN VOL 18, NO 8, PAGE(S) 2112 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME MAXYGEN APS, APPLICATION NO. 2003232176, UNDER INID (71) CORRECT THE NAME TO READ MAXYGEN APS; MAXYGEN HOLDINGS LTD. |